Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In single-group studies, marked clinical reactions to Crizotinib were observed in patients with Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m) . Whether Crizotinib is superior to standard chemotherapy in terms of efficacy is unknown (1)
An open-label, randomized, phase III treatment trial (parallel assignment) comparing crizotinib vs pemetrexed vs docetaxel in 347 patients with locally advanced or metastatic Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m) who had …